[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2010/130506,2010,A1Locationinpatent:Page/Pagecolumn103
[2]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US2015/231142,2015,A1Locationinpatent:Paragraph2345
1001413-01-9
338783-75-8
4332-79-0
338783-19-0
941869-22-3
941869-20-1
29106-51-2 | (2R,2'R,3S,3'R,4S)-2,2'-Bis(3,4-dihydroxyphenyl)-[4,8'-bichroman]-3,3',5,5',7,7'-hexaol | AA00BD00 | MFCD04039847
20443-38-3 | 5-Chloro-2-(chloromethyl)-1h-benzimidazole | AA00BD5N | MFCD00060503
26993-16-8 | 4-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)benzaldehyde | AA00BDCB | MFCD08704111
312531-87-6 | 4-(3,5-DIMETHYL-PYRAZOL-1-YLMETHYL)-BENZOIC ACID | AA00BDIV | MFCD01821597
223433-45-2 | 2-(Morpholinomethyl)phenylboronic acid | AA00BDQE | MFCD01319041
268209-95-6 | 3-tert-Butoxycarbonylamino-3-naphthalen-1-yl-propionic acid | AA00BDZ8 | MFCD02090687
201608-18-6 | 9-OXO-15S-HYDROXY-PROSTA-5Z,10,13E-TRIEN-1-OIC-3,3,4,4-D4 ACID | AA00BE6C | MFCD00135268
243990-54-7 | 3-(Benzyloxy)-4-methoxyphenylboronic acid | AA00BE9U | MFCD10696652
225101-64-4 | L-ALANINE-2-D1-N-FMOC | AA00BEGC | MFCD06658742
25672-31-5 | 2-(2-Formyl-6-methoxy-4-nitrophenoxy)acetic acid | AA00BEP3 | MFCD05625238